Dynamics of level of the tumor-associated marker SCCA in neoadjuvant superselective intra-arterial chemotherapy in patients with cervical squamous cell carcinoma

• Main Authors: N. S. Sergeeva (Author), N. V. Marshutina (Author), Kh. R. Maltsagova (Author), T. A. Karmakova (Author), I. I. Alentov (Author), S. V. Mukhtarulina (Author), T. I. Dezhkina (Author), A. G. Rerberg (Author), A. D. Kaprin (Author)
• Format: Book
• Published: ABV-press, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Evaluation of a tumor-associated marker SCCA (squamous cell carcinoma antigen) level is used in cervical squamous cell carcinoma (CC) to predict the course of the tumor process, monitor the effectiveness of chemo- and chemoradiotherapy, and for preclinical detection of recurrence in foll...